Shimadzu and Indigo BioSystems Partner to Leverage the Power of ASCENT Clinical Solutions on Ultra-Fast Mass Spectrometry Platforms - Tucson News Now

Shimadzu and Indigo BioSystems Partner to Leverage the Power of ASCENT Clinical Solutions on Ultra-Fast Mass Spectrometry Platforms


This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.


Automated Solution Unlocks the Power of Clinical Data and Accelerates LC-MS/MS Workflows

Columbia, MD (PRWEB) June 26, 2014

Shimadzu and Indigo BioSystems have announced a partnership to develop and market mass spectrometry solutions that simplify and accelerate clinical data acquisition and data review for applications in clinical research, forensic toxicology, and new drug development.

Under the terms of the agreement, Shimadzu is combining its ultra-fast mass spectrometry platforms with Indigo BioSystems' expert system software. ASCENT clinical analysis software is a comprehensive and powerful data analysis suite that interprets visual data results from instruments and automatically reviews the data for problematic results. Results are delivered quickly, consistently, and reliably.

ASCENT supports the scientist by automatically analyzing and reporting correct data and flagging only the outliers for expert review. The software speeds sample analysis by automating peak selection and peak area fitting. It also includes assay-specific quality assurance rules, which allow peaks to be automatically tested for quality. ASCENT operates using a web-browser interface requiring no software to be installed on computers in order to perform quantitative analysis.

Patrick Armstrong, director of Shimadzu Scientific Instruments R&D department said, Indigo BioSystems tools for high-throughput automated data analysis are highly developed with an impressive list of advanced features and greatly simplify clinical laboratory workflows. He added, We are excited to work with Indigo to leverage powerful ASCENT tools on Shimadzus ultra-fast mass spectrometry platforms.

Dr. Randall Julian, CEO of Indigo BioSystems said, Our partnership with Shimadzu will result in tighter integration between their excellent ultra-fast LC-MS/MS and our automated analysis software, ASCENT. This collaboration allows production labs to achieve maximum efficiency, superior quality, and rapid turnaround time. Shimadzus instruments, in combination with the ASCENT software, create a high-throughput, intelligent, production system.

For research use only. Not for use in diagnostic procedures.

About Shimadzu Scientific Instruments Inc.:

Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial, and Analytical Instruments. In the United States, SSI has a network of more than 50 locations providing local and regional sales, service and technical support. Visit for more information.

About Indigo BioSystems:

Indigo BioSystems is a provider of automated data analysis, data management, and data integration solutions to the clinical diagnostics reference laboratory and life sciences markets. Indigo's tools provide the clinical and pharmaceutical industries with analysis and interchange capabilities which permit complex experiments to be performed globally under full quality management protocols.

For the original version on PRWeb visit:

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact

Powered by WorldNow